CTOs on the Move

Biosense Webster

www.biosensewebster.com

 
Biosense Webster is offering you exposure to the best-in-class AF* practices through our Centers of Excellence program. Our Centers of Excellence provide you with the opportunity to fine tune your approach to PAF ablation by observing cases at
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Osiris Therapeutics

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.

Carter Dental Lab

Carter Dental Lab is a Stuttgart, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Young Dental Laboratory

Young Dental Laboratory Inc. is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Interbiolab

Interbiolab is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroOptx

MicroOptx is an early stage medical device company that is building a platform technology to shunt aqueous humor from the anterior chamber to the surface of the eye. Our mission is to change the way the World treats glaucoma – halting the devastating effects of this progressive disease. MicroOptx is led by recognized medical, industry and financial veterans who are dedicated towards preventing blindness.